Mohammed AbdelKhabir currently serves as EFG Hermes Group Chief Financial Officer. Prior to his current post, Mohamed joined EFG Hermes’ Investment Banking Division in early 2008 and remained with the IB division until March 2016 where he served as director.
Mohammed’s notable transactions during his investment banking tenure include: the IPO of Integrated Diagnostics Holding (IDH) through a secondary offering worth USD 334 million on the London Stock Exchange (LSE), the sale of a leading hospital in Egypt to the Abraj Group, the merger between Al Borg and Al Mokhtabar laboratories, the Egyptian Nitrogen Products Company (ENPC) syndicated loan worth USD 1.05 billion, and the issuance of Orascom Development Holding (ODH) EDRs worth USD 1.8 billion.
Previously, Mohammed held the position of Financial Planning Manager at Procter and Gamble in the Corporate Finance divisions with a focus on financial planning, budgeting, corporate restructure, integration, and profit forecasting.
Mohammed holds a BA in Business Administration from The American University in Cairo (AUC) with a concentration in Finance where he graduated with high honors, and is a CFA charter holder.